Rajni Yadav

Rajni Yadav

Kalinga University, Chhattisgarh, India

Profile ID RP-000-0046 Joined 2023-01-13 3 articles
0Connections
14
Total Views
3
Total Publications
32
Publication Views

Articles(3)

Authors: Rajni Yadav, Megha Jha, Diksha Jat, Deepak Kumar Jain

DOI: 10.18231/j.ijcaap.2022.035

Volume7
Issue4
Pages171-178
Abstract

In current years, pulsatile drug release systems (PDRS) are ahead raising attention as compared to conventional drugs. In this delivery system, the drug is liberate quickly after a well defined insulate-time, could be helpful for many medicines or treatments. It can be labeled in single and a couple of-pulse structures. Other structures consist of a drug-enclosed core, enclosed by means of a swelling layer and an outer layer is insoluble, however coating with semipermeable polymer. The lag time earlier to the rupture is specifically controlled via: the penetration and mechanical houses of the coated polymer and the behaviour of swelling depend on the swelling layer. As is within the residing frame frequently observed that, many fundamental capabilities are regulated with the aid of brief or pulsed launch of bioactive substances at a precise site and time. Therefore its miles grave to expand novel drug transport systems to attain pulsed launch of a sure amount of medicine a good way to imitate the feature of the dwelling systems, whilst reduce undesirable side results. Particular interest has been given to the thermally receptive poly (N-isopropylacrylamide) and its imitative hydrogels. Pulsatile drug transport is a machine that, by means of handing over drug at the right vicinity, right amounts and in proper time, grips suitable assures of benefit to the patients affected by continual problems like high blood pressure, allergies, arthritis. Keywords: Lag time, Pulsatile drug release, Rupturable coating

Authors: Rajni Yadav, Megha Jha, Shilpi Prasad, Diksha Jat, Deepak Kumar Jain

DOI: 10.18231/j.jpbs.2022.003

Volume10
Issue1
Pages7-16
Abstract

Mayaro virus (MAYV) has haggard increasing interest as an arthropod-borne virus causes eruptions among the human populations of the Western Hemisphere and is transmitted mostly by Hemagogus mosquitoes. MAYV travels in high-density tropical forests or rural areas of Central and South America origin a disease characterized by maculopapular skin rash, high-grade fever and manifest arthralgia that in some patients can continue for extended periods following infection and may be misunderstand as chikungunya. The virus stays alive in sylvatic cycles among mosquitoes and primate reservoirs such as marmosets. Though forest-residence mosquitoes are considered as imperative vectors for MAYV, it has been shown prior to that the virus can contaminate and potentially be transmitted by the mosquitoes, and Although only a little eruptions involving MAYV have been accounted, in the previous years the number of MAYV illness has improved in the northern and central regions of Brazil and many part of world. Disease by MAYV can make mayaro virus disease (MAYVD) which is frequently a clinically identified, sharp, feverish illness connected with extended and painful joint inflammation and swelling. MAYVD may be clinically indistinguishable from chikungunya fever, malaria, dengue, rabies, measles or other arboviral diseases. The full range of disease, routes of infection, virus shedding, sequelae and any rarer means of spread remain undefined. At present, there are no precise marketable tools for the diagnosis of MAYV and utilize of serological methods can be exaggerated by cross-reactivity and the window period. A diagnosis based on clinical and epidemiological data alone is still premature. Therefore, new entomological investigate is necessary and new extremely precise molecular diagnostic methods should be urbanized. This paper presents a systematic and present review of the published MAYV literature ranging from its original report to current eruptions and from the essential virus traits to the clinical and epidemiological traits of this disease. Keywords: Mayaro virus, Alphavirus, Chikungunya virus, Epidemiology, Mosquito, Arthralgia

Authors: Rajni Yadav, Sandip Prasad Tiwari, Joseph Galgano

DOI: 10.18231/j.ijcaap.2022.008

Volume7
Issue1
Pages44-50
Abstract

The current pandemic spreaded worldwide, COVID 19 is a major disease of concern as it is caused around 4 million death as per records of World Health Organization (WHO). The mode of transmission was so rapid that within 12 months 300 million people were effected with it. COVID 19 is a viral infection of SARS CoV 2 virus and developing vaccine for this virus was the main approach to protect the lives of people. Cy the starting of 2021 around 165 vaccines were under pre-clinical development and 101 vaccines were under clinical drug trials. By the end of 2021 World Health Organization (WHO) approved 18 vaccines as safe and effective and also for emergency use. The control of such infection can only be done by effective immunization programs. In this research findings an approach has been made to highlight the main areas of vaccine and list of approved vaccines. The SARS CoV 2 virus is continuously producing strain and the vaccines invented are not that much effective on these strains. The advancements possible in the identifying new COVID 19 vaccines is discussed here. The only way to free the world from this pandemic ids development and usage of effective COVID 19 vaccines to the people all over worldwide. Keywords: SARS CoV 2, DNA, Vaccine

No matching articles

Try another word from the title, author or DOI.

Brief Bio

No bio added yet.

Affiliations

Nothing added yet.

Education

Nothing added yet.

Honors & Awards

Nothing added yet.

Society Memberships

Nothing added yet.

Expertise

Nothing added yet.

Specialty

Nothing added yet.

Other Online Pages

Followers(0)

Nobody here yet.

Following(0)

Nobody here yet.